Vascular Ehlers-Danlos Syndrome: Mortality Age
The average life expectancy for patients with vascular Ehlers-Danlos syndrome (vEDS) is 51 years, though median survival has been reported as low as 48 years in some cohorts, with a median age at death of 31 years in surgical series. 1, 2
Key Mortality Data
The most authoritative and recent data comes from the 2024 ESC Guidelines, which clearly state that life expectancy is reduced to an average of 51 years in patients with vEDS 1. This represents the most comprehensive contemporary assessment of mortality in this population.
However, the prognosis varies significantly based on:
Genotype-Phenotype Correlation
- Null variants (producing no gene product or complete absence of function) demonstrate a better outcome compared to other COL3A1 variants 1
- Different COL3A1 pathogenic variants correlate with varying onset and severity of arterial pathology 3
Historical Context
Older data from 2002 reported a median survival of 48 years 2, while a 2013 surgical series found a median age at death of only 31 years 4. The discrepancy likely reflects:
- Publication bias toward more severe cases requiring surgical intervention
- Improved outcomes with modern multidisciplinary management
- Selection bias in surgical cohorts representing the most severe complications
Clinical Trajectory
Age of Onset
- Complications are rare during infancy
- 25% of affected individuals experience complications before age 20
- 80% experience complications before age 40 2
- Clinical complications may start during adolescence and repeat at unpredictable intervals 1
Recurrence Rate
The rate of recurrent organic complications is 1.6 events per 5-year period 1, emphasizing the chronic, progressive nature of this condition.
Impact of Management on Survival
Critical caveat: The 2024 ESC Guidelines explicitly state that "prognosis improves when patients are properly managed" 1. This suggests that the 51-year average life expectancy may represent a mix of optimally and suboptimally managed patients, and contemporary multidisciplinary care may extend survival beyond this figure.
Proper management includes:
- Regular vascular surveillance (annual imaging)
- Strict blood pressure control
- Celiprolol therapy (shown to reduce vascular morbidity)
- Lifestyle modifications
- Avoidance of unnecessary invasive procedures
Primary Cause of Death
Arterial rupture accounts for most deaths in vEDS 2, with the most common complications involving medium-sized arteries including dissections, aneurysms, arterial ruptures, and arteriovenous fistulas 1.